Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Personalized risk prediction of postoperative cognitive impairment - rationale for the EU-funded BioCog project.
European psychiatry : the journal of the Association of European Psychiatrists·2018
Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Ex vivo Evaluation of Live-MB2 and CX-2 Biotic Strains on Inflammatory and Barrier-Related Biomarkers in a Human Skin Atopic Dermatitis-Like Model.
Clinical, cosmetic and investigational dermatology·2026
A tiered tissue-based framework for diagnosing invasive fungal diseases: Integrating histopathology with targeted and metagenomic sequencing.
Diagnostic microbiology and infectious disease·2026
Clinical application of serum Mac-2-binding protein glycosylation isomer in the diagnosis of liver fibrosis: a meta-analysis.
Cancer treatment and research communications·2026